This study aims to explore the possibility of using a multilayer artificial neural network for the classification between children with autism spectrum disorder (ASD) and typically developing (TD) children based on short-time spontaneous hemodynamic fluctuations. Spontaneous hemodynamic fluctuations were collected by a functional near-infrared spectroscopy setup from bilateral inferior frontal gyrus and temporal cortex in 25 children with ASD and 22 TD children. To perform feature extraction and classification, a multilayer neural network called CGRNN was used which combined a convolution neural network (CNN) and a gate recurrent unit (GRU), since CGRNN has a strong ability in finding characteristic features and acquiring intrinsic relationship in time series. For the training and predicting, short-time (7 s) time-series raw functional near-infrared spectroscopy (fNIRS) signals were used as the input of the network. To avoid the over-fitting problem and effectively extract useful differentiation features from a sample with a very limited size (e.g., 25 ASDs and 22 TDs), a sliding window approach was utilized in which the initially recorded long-time (e.g., 480 s) time-series was divided into many partially overlapped short-time (7 s) sequences. By using this combined deep-learning network, a high accurate classification between ASD and TD could be achieved even with a single optical channel, e.g., 92.2% accuracy, 85.0% sensitivity, and 99.4% specificity. This result implies that the multilayer neural network CGRNN can identify characteristic features associated with ASD even in a short-time spontaneous hemodynamic fluctuation from a single optical channel, and second, the CGRNN can provide highly accurate prediction in ASD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.